Broker M&A Valuation Under Commission Reform Uncertainty India 2026: Revenue Quality, Diligence, and Earn-Out Design

Indian broker M&A entered 2026 with two opposing forces acting on price. On the demand side, the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025, in force from 5 February 2026, opened 100 percent FDI in insurance intermediaries, widening the buyer pool to global brokers and financial sponsors who previously needed Indian majority partners. The same Act introduced perpetual intermediary licences, removing renewal risk from the asset being bought, and composite licences that expand what a broking platform can become.

On the supply side of uncertainty, the same Act restored IRDAI's statutory power to cap distributor commissions, partially unwinding the legal basis of the deregulated era created by the IRDAI (Payment of Commission) Regulations, 2023. In June 2026 the regulator published the draft IRDAI (Insurance Intermediaries) (Amendment) Regulations, 2026, which, if notified, would force intermediaries to disclose intermediation revenue from insurers in a separate schedule to their financials, file audited statements with IRDAI by 30 September annually, publish them on their websites, and meet stricter disclosure above INR 10 crore of commission income. And in July 2026, press reporting (Business Standard, 3 July 2026) described a commission-rules overhaul under preparation, with a consultation paper expected by end-July: staggered trail commissions in place of upfront payouts that reach roughly 40 percent of first-year premium on some life and health products, effort-based remuneration, and possible caps by product type, tenure, and complexity.

Every one of those reform items is a proposal or a draft except the Act itself, but a buyer pricing a broking firm today cannot ignore them. The result is not a frozen market; deals are closing. What has changed is how the price is built: revenue quality analysis has displaced headline revenue multiples, diligence has acquired a regulatory-scenario layer, and earn-outs have become the standard instrument for sharing reform risk that neither side can price with confidence.

Sophisticated buyers now decompose a target's revenue into three buckets and apply different effective multiples to each. The bucket shares, not the headline number, drive the blended valuation.

Bucket one: upfront-dependent commission. Commission earned at placement on products where remuneration is front-loaded, with the life and retail health heavy payouts (approaching 40 percent of first-year premium in the worst cases) at the extreme. This is the revenue most exposed to a trail-commission rule: a reform that staggers payment over the policy life defers the cash and makes part of it contingent on persistency the target has never had to measure. Buyers apply the deepest haircuts here, discounting both the multiple and, in scenario cases, the revenue base itself.

Bucket two: renewal and recurring commission. Commission on a seasoned commercial and group book that renews predictably. This bucket is exposed to rate compression (caps, EOM-driven insurer repricing) but not to existential timing risk, and demonstrated retention above roughly 85 to 90 percent on commercial lines makes it behave like an annuity. Under a trail regime this bucket arguably gains relative value, because a persistency-backed book converts cleanly into a contracted receivable stream.

Bucket three: fee income. Client-paid fees for risk advisory, claims consulting, programme design, and employee-benefits administration. This revenue sits outside commission regulation entirely: no cap, no trail rule, no board-policy dependence. It earns the premium multiple, and in current negotiations it is common to see fee income valued at an effective multiple 30 to 50 percent above commission income of equal size, stated as an indicative market pattern rather than a published statistic.

As orientation, Indian broking transactions in recent years have clustered around 8 to 14 times EBITDA (roughly 1.5 to 3.5 times revenue) depending on scale, growth, and specialisation, as indicative estimates. The reform pipeline has not moved that headline band much; it has widened the spread within it. Two firms with identical EBITDA can now legitimately price 3 to 4 turns apart on revenue-mix grounds alone.

Take two targets, each with INR 25 crore of revenue and INR 6 crore of EBITDA.

Target A earns 55 percent of revenue from retail life and health distribution with heavy first-year commission, 35 percent from commercial renewals, and 10 percent from fees. Target B earns 20 percent from upfront-dependent products, 55 percent from a commercial and group renewal book with 91 percent retention, and 25 percent from fees under multi-year advisory retainers.

A buyer running the three-bucket analysis with illustrative effective multiples (say 6 to 8 times EBITDA-equivalent on upfront-dependent income, 10 to 12 times on persistency-backed renewals, 13 to 15 times on fees) arrives at a blended valuation for Target A around INR 45 to 55 crore, and for Target B around INR 65 to 75 crore. Same headline financials, roughly a 40 percent price gap, entirely attributable to how each rupee of revenue behaves under the reform scenarios.

The scenario layer widens the gap further. Model a trail-commission rule applied to Target A's upfront book: transition-year cash collections drop materially, and a slice of revenue becomes contingent on persistency that Target A has never tracked. Model the same rule on Target B: the renewal book's economics barely move, and its documented retention becomes a financeable asset. Buyers increasingly present these scenario models to sellers during price negotiation, which has changed the tone of processes: the argument is no longer whether reform will happen but which target survives it better.

Commission-reform uncertainty has added a distinct layer to broker due diligence. Beyond the standard legal, tax, and client-concentration workstreams, buyer question lists in 2026 processes consistently include the following.

1. Realised yield by line and insurer. Not rate agreements but actual commission received divided by premium placed, trailing 24 months, cell by cell. Buyers reconcile this against insurer statements to find leakage and against market ranges to find yields that look unsustainably high, since above-market yields are repricing risk, not value.
2. Contingent income share. What portion of revenue is reward-and-recognition, volume bonuses, or profit-linked variable income under insurer board-approved policies? This income reprices annually at insurer discretion inside the EOM envelope and gets a lower multiple, or in conservative models is excluded from run-rate revenue.
3. Exposure to high-upfront products. Revenue share from products where first-year remuneration exceeds, say, 20 percent of premium, the population most exposed to a staggered-commission rule.
4. Persistency and retention. Policy-level renewal rates by line for at least two years, plus mid-term cancellation experience. This is the number that determines what the book is worth under a trail regime.
5. Disclosure readiness. Can the target's financials already produce the separate intermediation-revenue schedule the draft 2026 intermediary regulations contemplate? Firms above the INR 10 crore commission-income threshold in the draft face stricter disclosure; buyers check whether reported revenue would survive publication on the firm's own website without client or insurer friction.
6. Related-party and pass-through arrangements. Referral payouts, sub-broking splits, and any arrangement that would look uncomfortable in an audited, IRDAI-filed, publicly published schedule. What was once a tax question is now a franchise-risk question.
7. Licence and governance status. Perpetual licences under the 2025 Act have simplified this item, but buyers verify compliance history, since the value of a perpetual licence is conditional on it not being suspended.

When neither side can price reform risk, the deal structure has to hold it. Earn-outs have shifted from growth instruments to regulatory risk-sharing instruments, and several design patterns are becoming standard in Indian broker deals.

The retained-revenue earn-out. A typical structure pays 55 to 70 percent of headline value at closing, with the balance over two to three years keyed to revenue actually retained and collected, measured at post-reform commission rates rather than at signing-date rates. If a trail rule defers cash or a cap compresses yields, buyer and seller share the impact in agreed proportions instead of litigating a material-adverse-change clause.

Bucket-specific earn-out rates. Sharper structures apply different earn-out credit to different revenue: fee income and renewals retained at full credit, upfront-dependent commission at partial credit unless converted into renewals or fees during the earn-out period. This pays the seller for actively migrating revenue quality after closing, which is exactly what the buyer wants done.

Regulatory collars. Deals increasingly define named regulatory events (notification of trail-commission rules, product-type caps, final intermediary disclosure regulations) with pre-agreed price adjustments or measurement-period extensions if the event lands inside the earn-out window. A collar converts an unpriceable uncertainty into a bounded, contractual one.

Persistency warranties and holdbacks. Sellers warrant stated retention levels; a holdback of 5 to 10 percent of consideration releases against actual renewal performance. This is the mechanism most directly responsive to a trail regime, since it prices the same persistency risk the regulation would create.

With the commission consultation paper expected at end-July 2026 and final rules some quarters behind it, both sides of the market face a timing question.

For sellers, the uncomfortable truth is that revenue-mix migration takes two renewal cycles and valuation credit follows evidence, not intention. The practical sequence: first, build the persistency and revenue-mix MIS described above, since it is cheap, fast, and moves price immediately. Second, convert the largest accounts to fees where the economics support it; every crore of commission converted to fee income before a process starts is worth materially more than the same crore left as commission. Third, get the financials audit-ready against the draft disclosure regulations, including the separate intermediation-revenue schedule, so the buyer's disclosure-readiness question has a one-word answer. Fourth, decide honestly whether to sell before final rules (accepting an earn-out that shares reform risk) or after (accepting execution risk but selling certainty). Firms with strong renewal books lose little by waiting; firms heavy in upfront-dependent revenue are, bluntly, selling a depreciating uncertainty and should prefer structured deals sooner.

For buyers, the window before final rules is the moment of maximum information advantage for those who have modeled the scenarios. Targets without persistency data can be priced conservatively with upside shared through earn-outs; targets with strong data can be pre-empted before the post-clarity repricing that will likely lift quality assets. The 100 percent FDI route means international strategics are running the same screens, and the mid-market consolidation already underway gives sponsors platform logic for add-ons.

The firms that will look back on 2026 as a good vintage, on either side of the table, are those that treated commission reform as a measurable input to structure rather than a reason to wait. Uncertainty this legible rarely stays unpriced for long.